MARKET

ADTX

ADTX

Aditxt Inc
NASDAQ
1.820
-1.070
-37.02%
After Hours: 1.800 -0.02 -1.10% 18:23 03/13 EDT
OPEN
1.960
PREV CLOSE
2.890
HIGH
2.000
LOW
1.760
VOLUME
1.05M
TURNOVER
--
52 WEEK HIGH
14,034.60
52 WEEK LOW
1.760
MARKET CAP
942.50K
P/E (TTM)
-0.0000
1D
5D
1M
3M
1Y
5Y
1D
Aditxt acquires Ignite Proteomics in $36M preferred stock deal; shares down
Seeking Alpha · 5h ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 6h ago
Aditxt Finalizes Ignite Proteomics Acquisition, Strengthening Oncology Focus
TipRanks · 10h ago
Aditxt acquires Ignite Proteomics in $36M transaction
TipRanks · 10h ago
Aditxt acquires Ignite Proteomics in deal valued at USD 36 million
Reuters · 11h ago
ADITXT INC - BUYS IGNITE FOR 36,000 SERIES A-2 CONVERTIBLE PREFERRED SHARES, STATED VALUE $36.0 MLN
Reuters · 11h ago
*Aditxt Acquires Ignite Proteomics To Address A Critical Challenge In Cancer Care: Optimizing Therapy Selection >ADTX
Dow Jones · 11h ago
Press Release: Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection
Dow Jones · 11h ago
More
About ADTX
Aditxt, Inc. is a social innovation platform dedicated to accelerating promising health innovations. It develops and commercializes technologies with a focus on monitoring and modulating the immune system. Its portfolio includes Adimune, Inc., developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity, and allergies; Adivir, Inc., focused on identifying, developing, and commercializing new ways to treat infectious diseases, and Pearsanta, Inc., offering personalized lab testing, backed by CLIA-certified and CAP-accredited monitoring center. Adimune, Inc's immune modulation product candidate, ADI-100, is based on the Apoptotic DNA Immunotherapy platform technology, utilizes a novel approach that mimics the way bodies naturally induce tolerance to own tissues. It also offers electroencephalography (EEG) brain monitoring technologies and devices, including NeuroCap and NeuroEEG for telehealth and tele-neurology applications.

Webull offers Aditxt Inc stock information, including NASDAQ: ADTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADTX stock methods without spending real money on the virtual paper trading platform.